About 430,000 results
Open links in new tab
Wave Life Sciences Announces Positive Interim Data from …
Wave Life Sciences Stock Surges On Promising Interim Data From …
Wave Life Sciences’ WVE-N531 Shows Best-in-Class Potential in …
Wave surfs DMD success to regulators' doors, sending stock up
Wave Life Sciences: Spiking On Strong DMD Data, But Not Fully …
Wave Life Sciences Reports Positive Data From Phase 2 FORWARD …
Wave stock gains on Duchenne therapy data (NASDAQ:WVE)
Wave Life Sciences Shares Climb Premarket on Duchenne Study Data
FDA gives WVE-N531, exon 53 skipping therapy, supportive status
Wave Life Sciences' stock soars 51% after biotech posts positive …
- Some results have been removed